---
title: Clarenta vs ExperTrials
slug_a: comac-medical
slug_b: expertrials
site: cro
review_signal_gate: closed
canonical_path: /compare/comac-medical/expertrials
---

# Clarenta vs ExperTrials

Side-by-side profile data from each company listing on this directory.

## Clarenta

- Profile: [/companies/comac-medical](/companies/comac-medical)

Clarenta — Clarenta (formerly Comac Medical Group) is a pan-European CRO offering full-service trial delivery and early-phase studies, including first-in-human and PK work. It runs a Phase I unit in Sofia and has depth in oncology and rare diseases.

Services: 8. Modalities: 0. Indications: 7. Locations: 10. Certifications: 0. The strongest documented coverage currently appears in locations (10).

### Services

- Clinical Trial Services
- Phase I Clinical Trials
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Regulatory Affairs
- CMC Regulatory Submission Support

### Modalities

- Data not yet provided.

### Indications

- Oncology
- Neurology
- Psychiatry
- Rare Disease
- Respiratory
- Dermatology
- Gastroenterology

### Phases

- Phase I
- Preclinical (General)

### Sourcing models

- Full-Service Outsourcing (FSO)

## ExperTrials

- Profile: [/companies/expertrials](/companies/expertrials)

ExperTrials — European-based full-service CRO supporting biotech and medtech companies from Phase I through Phase IV and market access, with 80+ senior clinical research associates across Europe and the USA.

Services: 12. Modalities: 0. Indications: 6. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (12).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs
- EU EMA Regulatory Strategy
- Device & Combination Product Services

### Modalities

- Data not yet provided.

### Indications

- Oncology
- Neurology
- Cardiovascular
- Infectious Disease
- Rare Disease
- Gastroenterology

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)